SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001410578-23-000269
Filing Date
2023-03-15
Accepted
2023-03-15 14:45:06
Documents
82
Reference 429
333-266476

Document Format Files

Seq Description Document Type Size
1 POS AM qnrx-20221231xposam.htm   iXBRL POS AM 2293551
2 EX-23.1 qnrx-20221231xex23d1.htm EX-23.1 2653
3 EX-23.2 qnrx-20221231xex23d2.htm EX-23.2 2823
4 GRAPHIC qnrx-20221231xposam008.jpg GRAPHIC 9935
  Complete submission text file 0001410578-23-000269.txt   7740181

Data Files

Seq Description Document Type Size
5 EX-101.SCH qnrx-20221231.xsd EX-101.SCH 69012
6 EX-101.CAL qnrx-20221231_cal.xml EX-101.CAL 49353
7 EX-101.DEF qnrx-20221231_def.xml EX-101.DEF 263804
8 EX-101.LAB qnrx-20221231_lab.xml EX-101.LAB 523929
9 EX-101.PRE qnrx-20221231_pre.xml EX-101.PRE 410857
76 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20221231xposam_htm.xml XML 922978
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: POS AM | Act: 33 | File No.: 333-269543 | Film No.: 23734692
SIC: 3841 Surgical & Medical Instruments & Apparatus